Open AccessComplete remission of nephrotic syndrome and acute kidney injury in crescentic IgA nephropathy: Role of mycophenolate sodium
Author(s) -
Dinesh Bhandari,
Kenar D. Jhaveri,
Hitesh H. Shah
Publication year - 2016
Publication title -
indian journal of nephrology/indian journal of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.317
H-Index - 24
eISSN - 1998-3662
pISSN - 0971-4065
DOI - 10.4103/0971-4065.175985
Subject(s) - medicine , mycophenolate , nephropathy , nephrotic syndrome , cyclophosphamide , glomerulonephritis , gastroenterology , acute kidney injury , urology , kidney , chemotherapy , endocrinology , transplantation , diabetes mellitus
Optimal therapy and prognosis of crescentic-IgA nephropathy (C-IgAN) are not known. Reported treatment options for C-IgAN include combination of corticosteroids and cyclophosphamide for 6 months. The role of mycophenolate sodium in C-IgAN is unknown. We report a case of C-IgAN that was successfully treated with combination immunosuppressive therapy.